Active

Can unravelling tangled DNA be the key to a new cancer cure?

Cancer types:

General cancer research

Project period:

Research institute:

University of Crete

Award amount:

£229,100

Location:

Greece

George Zachos Headshot
Researcher Dr George Zachos, cell biologist, football fan and lover of Ian Rankin books

Dr Zachos and his team in Greece are investigating how cells manage to stabilise DNA changes, and if targeting these mechanisms could stop cancer. This important work could one day lead to a completely different type of treatment for people with the disease.

Why is this research needed?

More people are surviving cancer than ever before. But it is still one of the leading causes of death worldwide. The only way we can find new treatments, and better ways to diagnose and prevent the disease, is by digging down and finding out exactly how cancer develops.

One area of huge interest is in understanding how DNA changes in cells are linked to cancer. Thanks to Curestarter funding, Dr George Zachos can now do vital discovery work in this area, leading to a better understanding of how cancer develops, and unearthing brand new ideas for cancer cures.  

We have made large strides in the last 30 years and several types of cancer can now be cured. I strongly believe that investing in cancer research can help us make cancer a disease of the past.

Dr George Zachos
George Zachos Team Photo

What is the science behind this project?

Healthy cells in your body divide millions of times every day, and every time a cell divides, its DNA must also divide. This usually happens without a problem. But sometimes, the long strings of DNA in our cells can become tangled, and form DNA ‘bridges’. This can also happen in cancer cells.

If these bridges are left unsupported they can break, which can be catastrophic for the cell. Both healthy cells and cancer cells get around this problem by stabilising the bridges with specially made molecular ‘patches’. Dr Zachos and his team suspect that preventing cancer cells from patching up DNA bridges could open up a ‘backdoor’ route to kill cancer cells.

They are using specialised molecular techniques to investigate the machinery that cells use to stabilise DNA bridges, and using drugs to stop cancer cells from making molecular patches, then studying if the resulting DNA damage is so severe it kills the cell. To do this the team need to use a new and very strong type of microscope technology – which Curestarter funding has specifically helped to buy. 

What difference could this project make to patients in the future? 

Overall this study will help us to understand a very important and fundamental mechanism that is central to cancer cell biology, and could also lead to a completely different approach to treating cancer. The more cures that we can develop like this, the fewer lives will be lost to cancer.

Worldwide Cancer Research lab coat

Donate to support more research like this

By choosing to make a donation today you can help us fund more of these bright ideas for new ways to prevent, diagnose, and treat cancer. 

Related projects

Andres Hidalgo Headshot

Active Spain

Lung cancer

How do cancer cells modify white blood cells to help tumours grow?

Researchers want to help immunotherapy work for more cancer patients by understanding how cancers hijack our immune system and preventing this happening 

Researcher: Dr Andrés Hidalgo

Understanding how cancer cells modify white blood cells to help tumours grow
Andrew Beekman and Team

Active United Kingdom

General cancer research

Can we stop cancer becoming resistant to chemotherapy?

Chemotherapy can sometimes stop working, so this project is hoping to better understand why and find ways to give more, better options to cancer patients.

Researcher: Dr Andrew Beekman

Stopping cancer becoming resistant to chemotherapy
Tim Elliott and Team

Active United Kingdom

General cancer research

Can we predict which patients will respond to immunotherapy?

This project hopes to open up exciting possibilities for personalised cancer treatment by finding how to predict which patients will respond best to treatment.

Researcher: Professor Tim Elliott

Finding ways to predict which patients will respond to immunotherapy
Share this page